Obesity, asthma, and oxidative stress

Journal of Applied Physiology

Volumn 108, Issue 3, 2010, Pages 754-759

  Holguin, Fernando ^a   Fitzpatrick, Anne ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

8 Isoprostanes; Adipokines

Indexed keywords

8 EPI PROSTAGLANDIN F2ALPHA; 8-EPI-PROSTAGLANDIN F2ALPHA; ADIPOCYTOKINE; AUTACOID; DRUG DERIVATIVE; PROSTAGLANDIN F2 ALPHA;

ANIMAL; ASTHMA; HUMAN; IMMUNOLOGY; LUNG; METABOLISM; OBESITY; OXIDATIVE STRESS; REVIEW; RISK FACTOR;

ADIPOKINES; ANIMALS; ASTHMA; DINOPROST; HUMANS; INFLAMMATION MEDIATORS; LUNG; OBESITY; OXIDATIVE STRESS; RISK FACTORS;

EID: 77949697927     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00702.2009     Document Type: Review

References (56)

1. Al Lawati NM, Patel SR, Ayas NT. Epidemiology, risk factors, and consequences of obstructive sleep apnea and short sleep duration. Prog Cardiovasc Dis 51: 285-293, 2009.
2. Alkhalil M, Schulman E, Getsy J. Obstructive sleep apnea syndrome and asthma: what are the links? J. Clin Sleep Med 5: 71-78, 2009.
3. Alkhalil M, Schulman ES, Getsy J. Obstructive sleep apnea syndrome and asthma: the role of continuous positive airway pressure treatment. Ann Allergy Asthma Immunol 101: 350-357, 2008.
4. Alonso-Fernandez A, Garcia-Rio F, Arias MA, Hernanz A, de la Pena M, Pierola J, Barcelo A, Lopez-Collazo E, Garcia AA. Effects of CPAP on oxidative stress and nitrate deficiency in sleep apnoea: a randomized trial. Thorax 64: 581-586, 2009.
5. Baraldi E, Carraro S, Alinovi R, Pesci A, Ghiro L, Bodini A, Piacentini G, Zacchello F, Zanconato S. Cysteinyl leukotrienes and 8-isoprostane in exhaled breath condensate of children with asthma exacerbations. Thorax 58: 505-509, 2003.
6. Barnes PJ. How corticosteroids control inflammation: Quintiles Rize Lecture 2005. Br J Pharmacol 148: 245-254, 2006.
7. Barnes PJ, Adcock IM, Ito K. Histone acetylation and deacetylation: importance in inflammatory lung diseases. Eur Respir J 25: 552-563, 2005.
8. Bennett WD, Hazucha MJ, Folinsbee LJ, Bromberg PA, Kissling GE, London SJ. Acute pulmonary function, response to ozone in young adults as a function of body mass index. Inhal Toxicol 19: 1147-1154, 2007.
9. Beuther DA, Sutherland ER. Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care Med 175: 661-666, 2007.
10. Carpagnano GE, Kharitonov SA, Resta O, Foschino-Barbaro MP, Gramicdoni E, Barnes PJ. 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. Chest 124: 1386-1392, 2003.
11. Chen Y, Home SL, Dosman JA. Body weight and weight gain related to pulmonary function decline in adults: a six year follow up study. Thorax 48: 375-380, 1993.
12. Couillard C, Ruel G, Archer WR, Pomerleau S, Bergeron J, Couture P, Lamarche B, Bergeron N. Circulating levels of oxidative stress markers and endothelial adhesion molecules in men with abdominal obesity. J Clin Endocrinol Metab 90: 6454-6459, 2005.
13. Davis WA, Knuiman M, Kendall P, Grange V, Davis TM. Glycemic exposure is associated with reduced pulmonary function in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care 27: 752-757, 2004.
14. Ercan H, Birben E, Dizdar EA, Keskin O, Karaaslan C, Soyer OU, Dut R, Sackesen C, Bester T, Kalayci O. Oxidative stress and genetic and epidemiologic determinants of oxidant injury in childhood asthma. J Allergy Clin Immunol 118: 1097-1104, 2006.
15. Fitzpatrick AM, Teague WG, Holguin F, Yeh M, Brown LA. Airway glutathione homeostasis is altered in children with severe asthma: evidence for oxidant stress. J Allergy Clin Immunol 123: 146-152, 2009.
16. Fujita K, Nishizawa H, Funahashi T, Shimomura I, Shimabukuro M. Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome. Circ J 70: 1437-1442, 2006.
17. Holguin F, Fitzpatrick A, Anderson A, Brown LA. Airway adipokines and airway oxidative stress in lean and obese controls and asthmatics (Abstract). Am J Respir Crit Care Med 179: A2510, 2009.
18. Holguin F, Rojas M, Hart CM. The peroxisome proliferator activated receptor gamma (PPAR gamma) ligand rosiglitazone modulates bronchoalveolar lavage levels of leptin, adiponectin, and inflammatory cytokines in lean and obese mice. Lung 185: 367-372, 2007.
19. Johnston RA, Theman TA, Lu FL, Terry RD, Williams ES, Shore SA. Diet-induced obesity causes innate airway hyperresponsiveness to methacholine and enhances ozone-induced pulmonary inflammation. J Appl Physiol 104: 1727-1735, 2008.
20. Jonasson S, Hjoberg J, Hedenstierna G, Basu S. Allergen-induced formation of F2-isoprostanes in a murine asthma model identifies oxidative stress in acute airway inflammation in vivo. Prostaglandins Leukot Essent Fatty Acids 80: 1-7, 2009.
21. Joshi PC, Guidot DM. The alcoholic lung: epidemiology, pathophysiology, and potential merapies. Am J Physiol, Lung Cell Mol Physiol 292: L813-L823, 2007.
22. Jun J, Savransky V, Nanayakkara A, Bevans S, Li J, Smith PL, Polotsky VY. Intermittent hypoxia has organ-specific effects on oxidative stress. Am J Physiol Regul Integr Comp Physiol 295: R1274-R1281, 2008.
23. Keaney JF Jr, Larson MG, Vasan RS, Wilson PW, Lipinska I, Corey D, Massaro JM, Sutherland P, Vita JA, Benjamin EJ. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vase Biol 23: 434-439, 2003.
24. Koike Y, Hisada T, Utsugi M, Ishizuka T, Shimizu Y, Ono A, Murata Y, Hamuro J, Mori M, Dobashi K. Glutathione redox regulates airway hyperresponsiveness and airway inflammation in mice. Am J Respir Cell Mol Biol. 37: 322-329, 2007.
25. Komakula S, Khatri S, Mermis J, Savill S, Haque S, Rojas M, Brown L, Teague GW, Holguin F. Body mass index is associated with reduced exhaled nitric oxide and higher exhaled 8-isoprostanes in asthmatics. Respir Res 8: 32, 2007.
26. Lang JE, Williams ES, Mizgerd JP, Shore SA. Effect of obesity on pulmonary inflammation induced by acute ozone exposure: role of interleukin-6. Am J Physiol Lung Cell Mol Physiol 294: L1013-L1020, 2008.
27. Lange P, Parner J, Schnohr P, Jensen G. Copenhagen City Heart Study: longitudinal analysis of ventilatory capacity in diabetic and nondiabetic adults. Eur Respir J To: 1406-1412, 2002.
28. Litonjua AA, Sparrow D, Celedón JC, DeMolles D, Weiss ST. Association of body mass index with the development of methacholine airway hyperresponsiveness in men: the Normative Aging Study. Thorax 57: 581-585, 2002.
29. Lumeng CN, DelProposto JB, Westcott DJ, Saltiel AR. Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes. Diabetes 57: 3239-3246, 2008.
30. Malinska H, Oliyarnyk O, Hubova M, Zidek V, Landa V, Simakova M, Mlejnek P, Kazdova L, Kurtz TW, Pravenec M. Increased liver oxidative stress and altered PUFA metabolism precede development of non-alcoholic steatohepatitis in SREBP-1a transgenic spontaneously hypertensive rats with genetic predisposition to hepatic steatosis. Mol Cell Biochem. In press.
31. Mancuso P, Canetti C, Gottschalk A, Tithof PK, Peters-Golden M. Leptin augments alveolar macrophage leukotriene synthesis by increasing phospholipase activity and enhancing group IVC iPLA.2 (cPLA2gamma) protein expression. Am J Physiol Lung Cell Mol Physiol 287: L497-L502, 2004.
32. Montuschi P, Corradi M, Ciabattoni G, Nightingale J, Kharitonov SA, Barnes PJ. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asdima patients. Am J Respir Crit Care Med 160: 216-220, 1999.
33. Nadeem A, Chhabra SK, Masood A, Raj HG. Increased oxidative stress and altered levels of antioxidants in asthma. J Allergy Clin Immunol 111 : 72-78, 2003.
34. Nadeem A, Raj HG, Chhabra SK. Increased oxidative stress in acute exacerbations of asthma. J Asthma AT 45-50, 2005.
35. Ochs-Balcom HM, Grant BJ, Muti P, Sempos CT, Freudenheim JL, Browne RW, McCann SE, Trevisan M, Cassano PA, Iacoviello L, Schunemann HJ. Antioxidants, oxidative stress, and pulmonary function in individuals diagnosed widi asthma or COPD. Eur J Clin Nutr 60: 991-999, 2006.
36. Ogino K, Wang DH. Biomarkers of oxidative/nitrosative stress: an approach to disease prevention. Acta Med Okayama 61: 181-189, 2007.
37. Peters-Golden M, Swern A, Bird SS, Hustad CM, Grant E, Edelman JM. Influence of body mass index on the response to asthma controller agents. Eur Respir J 11: 495-503, 2006.
38. Petrosyan M, Perraki E, Simões D, Koutsourelakis I, Vagiakis E, Roussos C, Gratziou C. Exhaled breath markers in patients with obstructive sleep apnoea. Sleep Breath 12: 207-215, 2008.
39. Rahman I. Oxidative stress and gene transcription in asthma and chronic obstructive pulmonary disease: antioxidant merapeutic targets. Curr Drug Targets lnflamm Allergy 1: 291-315, 2002.
40. Roberts CK, Sindhu KK. Oxidative stress and metabolic syndrome. Life Sci 84: 705-712, 2009.
41. Saint-Pierre P, Bourdin A, Chanez P, Daures JP, Godard P. Are overweight asthmatics more difficult to control? Allergy 61: 79-84, 2006.
42. Samitas K, Chorianopoulos D, Vittorakis S, Zervas E, Economidou E, Papatheodorou G, Loukides S, Gaga M. Exhaled cysteinyl-leukotrienes and 8-isoprostane in patients with asthma and their relation to clinical severity. Respir Med 103: 750-756, 2009.
43. Schleicher E, Friess U. Oxidative stress, AGE, atherosclerosis. Kidney Int Suppl 106: S17-S26, 2007.
44. Shaheen M, Echeverry D, Oblad MG, Montoya MI, Teklehaimanot S, Akhtar AJ. Hepatitis C, metabolic syndrome, and inflammatory markers: results from, the Third National Health and Nutrition Examination Survey [NHANES III]. Diabetes Res Clin Pract 75: 320-326, 2007.
45. Shahid SK, Kharitonov SA, Wilson NM, Bush A, Barnes PJ. Exhaled 8-isoprostane in childhood asthma. Respir Res 6: 79, 2005.
46. Shirshev SV, Orlova EG. Molecular mechanisms of regulation of functional activity of mononuclear phagocytes by leptin. Biochemistry (Mose) 70: 841-847, 2005.
47. Sood A, Steffes M, Smith L, Holvoet P, Thyagarajan B, Jacobs D. Obesity-asthma association: is it explained by systemic oxidant stress? Chest 136: 1055-1062, 2009.
48. Steffes MW, Gross MD, Lee DH, Schreiner PJ, Jacobs DR Jr. Adiponectin, visceral fat, oxidative stress, and early macrovascular disease: the Coronary Artery Risk Development in Young Adults Study. Obesity (Silver Spring) 14: 319-326, 2006.
49. Stephens JW, Khanolkar MP, Bain SC. The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease. Atherosclerosis 202: 321-329, 2009.
50. Taylor B, Mannino D, Brown C, Crocker D, Twum-Baah N, Holguin F. Body mass index and asthma severity in the National Asthma Survey. Thorax 63: 14-20, 2008.
51. Vincent HK, Bourguignon CM, Taylor AG. Relationship of the dietary phytochemical index to weight gain, oxidative stress and inflammation in overweight young adults. J Hum Nutr Diet. In press.
52. Vincent HK, Innes KE, Vincent KR. Oxidative stress and potential interventions to reduce oxidative stress in overweight and obesity. Diabetes Obes Metab 9: 813-839, 2007.
53. Wu B, Fukuo K, Suzuki K, Yoshino G, Kazumi T. Relationships of systemic oxidative stress to body fat distribution, adipokines and inflammatory markers in healthy middle-aged women. Endocr J 56: 773-782, 2009.
54. Wu P, Roberts LJ, 2nd Shintani AK, Sheller JR, Minton PA, Higgins SB, Hartert TV. Changes in urinary dinor dihydro F(2)-isoprostane metabolite concentrations, a marker of oxidative stress, during and following asthma exacerbations. Free Radie Res 41: 956-962, 2007.
55. Yigla M, Tov N, Solomonov A, Rubin AH, Harlev D. Difficult-tocontrol asthma and obstructive sleep apnea. J Asthma 40: 865-871, 2003.
56. Zanconato S, Carraro S, Corradi M, Alinovi R, Pasquale MF, Piacentini G, Zacchello F, Baraldi E. Leukotrienes and 8-isoprostane in exhaled breath condensate of children with stable and unstable asthma. J Allergy Clin Immunol 113: 257-263, 2004.